{"transactions":[{"id":811503,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53084,"kind":"person","name":"Goodman Tony","position":1,"cik":"0001717971","reported_name":"Goodman Tony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-09T21:00:10.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":26510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted shares of common stock that vest in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":26523,"source":{"system":"sec-edgar","filing":"0001213900-26-042054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717971/000121390026042054/ownership.xml","form_type":"4"}},{"id":1127716,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53084,"kind":"person","name":"Goodman Tony","position":1,"cik":"0001717971","reported_name":"Goodman Tony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T20:01:30.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":94000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025."}],"balance_after":94000,"derivative":{"exercise_price":0.688,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":94000},"source":{"system":"sec-edgar","filing":"0001213900-25-050016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717971/000121390025050016/ownership.xml","form_type":"4"}},{"id":1559544,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53084,"kind":"person","name":"Goodman Tony","position":1,"cik":"0001717971","reported_name":"Goodman Tony","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-27T22:05:45.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024."}],"balance_after":42000,"derivative":{"exercise_price":1.35,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001213900-24-026706","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717971/000121390024026706/ownership.xml","form_type":"4"}},{"id":1878193,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53084,"kind":"person","name":"Goodman Tony","position":1,"cik":"0001717971","reported_name":"Goodman Tony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T20:41:22.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023."}],"balance_after":50000,"derivative":{"exercise_price":0.3025,"exercise_date":"2023-05-23","expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-23-043117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717971/000121390023043117/ownership.xml","form_type":"4"}},{"id":2220198,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53084,"kind":"person","name":"Goodman Tony","position":1,"cik":"0001717971","reported_name":"Goodman Tony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-28T22:02:41.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":25000,"derivative":{"exercise_price":1.23,"exercise_date":"2022-07-27","expiration_date":"2032-06-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-22-035649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717971/000121390022035649/ownership.xml","form_type":"4"}},{"id":2372190,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53084,"kind":"person","name":"Goodman Tony","position":1,"cik":"0001717971","reported_name":"Goodman Tony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-02-25T20:05:22.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022."}],"balance_after":40000,"derivative":{"exercise_price":2,"exercise_date":"2022-03-23","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-22-009440","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717971/000121390022009440/ownership.xml","form_type":"4"}},{"id":2869305,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53084,"kind":"person","name":"Goodman Tony","position":1,"cik":"0001717971","reported_name":"Goodman Tony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-02-10T22:51:16.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":40000,"derivative":{"exercise_price":3.11,"exercise_date":"2021-03-08","expiration_date":"2031-02-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-21-008162","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717971/000121390021008162/ownership.xml","form_type":"4"}},{"id":3224699,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53084,"kind":"person","name":"Goodman Tony","position":1,"cik":"0001717971","reported_name":"Goodman Tony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-03-06T00:18:07.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months."}],"balance_after":60000,"derivative":{"exercise_price":1.44,"exercise_date":"2020-04-03","expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001213900-20-005539","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717971/000121390020005539/ownership.xml","form_type":"4"}},{"id":3855127,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53084,"kind":"person","name":"Goodman Tony","position":1,"cik":"0001717971","reported_name":"Goodman Tony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T20:06:10.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 31, 2018, the reporting person purchased 7,000 units (the \"Units\") in the initial public offering (the \"IPO\") of Adial Pharmaceuticals, Inc. (the \"Company\") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2018, the reporting person purchased 7,000 units (the \"Units\") in the initial public offering (the \"IPO\") of Adial Pharmaceuticals, Inc. (the \"Company\") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO."}],"balance_after":7000,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001213900-18-010085","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1717971/000121390018010085/ownership.xml","form_type":"4"}},{"id":3855126,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":53084,"kind":"person","name":"Goodman Tony","position":1,"cik":"0001717971","reported_name":"Goodman Tony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T20:06:10.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 31, 2018, the reporting person purchased 7,000 units (the \"Units\") in the initial public offering (the \"IPO\") of Adial Pharmaceuticals, Inc. (the \"Company\") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2018, the reporting person purchased 7,000 units (the \"Units\") in the initial public offering (the \"IPO\") of Adial Pharmaceuticals, Inc. (the \"Company\") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO."}],"balance_after":8755,"source":{"system":"sec-edgar","filing":"0001213900-18-010085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717971/000121390018010085/ownership.xml","form_type":"4"}}]}